Latest Articles and Analysis

Stagnant CMS reimbursement rates since 2016 threaten addiction treatment provider closures and service access.

Restrictive Medicaid policies limit HCV treatment access through fibrosis restrictions and sobriety requirements.

Explores technology innovations in HIV care including mobile apps and drone pharmacy delivery.

Supreme Court allows states to ration hepatitis C care in prisons, setting dangerous precedent for incarcerated people.

Quarterly update on HCV treatment coverage across ADAPs, Medicaid, Veterans programs, and patient assistance options.

COVID-19 vaccination priority for people with HIV and chronic liver disease amid immunological risks.

Family courts and child welfare systems miss opportunities to address health needs and social determinants.

FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.

Quarterly Watch covering HCV treatment access across ADAPs and Medicaid, harm reduction programs, and COVID-19 impact on care.

COVID-19 caused a 50% drop in hospital HCV screening and 72% drop in primary care settings.

Narrowly divided Senate limits Biden's health policy agenda, making regulatory actions the primary reform path.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.

CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.